MANAGEMENT OF HIGH-DOSE MELPHALAN-INDUCED ORAL MUCOSITIS: OUR EXPERIENCE

被引:0
|
作者
Tartarone, Alfredo [1 ]
Matera, Rosella [1 ]
Iodice, Giovanni [1 ]
Romano, Gianpiero [1 ]
Coccaro, Maria [1 ]
Capobianco, Alba [1 ]
Bochicchio, Annamaria [1 ]
Vigliotti, Maria Luigia [1 ]
Mele, Giuseppe [1 ]
Di Leo, Pasquale [1 ]
Musto, Clelia [1 ]
Di Renzo, Nicola [1 ]
机构
[1] Ctr Riferimento Oncol Basilicata, Div Oncoematol, Rionero In Vulture, PZ, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:112 / 112
页数:1
相关论文
共 50 条
  • [21] Prospective Oral Mucositis Audit: Oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy - European blood and marrow transplantation mucositis advisory group
    Blijlevens, Nicole
    Schwenkglenks, Matthias
    Bacon, Pamela
    D'Addio, Alessandra
    Einsele, Hermann
    Maertens, Johan
    Niederwieser, Dietger
    Rabitsch, Werner
    Roosaar, Ann
    Ruutu, Tapani
    Schouten, Harry
    Stone, Rebecca
    Vokurka, Samuel
    Quinn, Barry
    McCann, Shaun
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (09) : 1519 - 1525
  • [22] Our experience with transdermal therapeutic system fentanyl in the pain management of high dose chemotherapy associated oral mucositis
    Tartarone, Alfredo
    Romano, Giampiero
    Ardito, Raffaele
    Barone, Lucia
    Guariglia, Roberto
    Musto, Clelia
    Coccaro, Maria
    Bochicchio, Annamaria
    Di Leo, Pasquale
    Capobianco, Alba
    ANNALS OF ONCOLOGY, 2006, 17 : 299 - 299
  • [23] Our experience with transdermal therapeutic system fentanyl in the pain management of high dose chemotherapy associated oral mucositis
    Tartarone, A.
    Romano, C.
    Ardito, R.
    Coccaro, M.
    Bochicchio, A. M.
    Di Leo, P.
    Capobianco, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 196 - 196
  • [24] Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis
    Schmidt, E.
    Thoennissen, N. H.
    Rudat, A.
    Bieker, R.
    Schliemann, C.
    Mesters, R. M.
    Zuehlsdorf, M.
    Mueller-Tidow, C.
    Berdel, W. E.
    ANNALS OF ONCOLOGY, 2008, 19 (09) : 1644 - 1649
  • [25] Genetics of high-dose methotrexate-induced oral mucositis: current perspectives
    Heil, Sandra G.
    PHARMACOGENOMICS, 2019, 20 (09) : 621 - 623
  • [26] Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis
    Schmidt, Eva
    Thoennissen, Nils H.
    Rudat, Annika
    Bieker, Ralf
    Schliemann, Christoph
    Mesters, Rolf M.
    Zuehlsdorf, Michael
    BLOOD, 2007, 110 (11) : 181B - 181B
  • [27] THE EXPERIENCE OF USING CAPHOSOL FOR ORAL MUCOSITIS PROPHYLAXIS IN PEDIATRIC HIGH-DOSE CHEMOTHERAPY RECIPIENTS
    Safonova, S. A.
    Punanov, Y. A.
    Roschina, N. V.
    Youkhta, T. V.
    Galunova, T. Y.
    Morozova, E. V.
    Kazantsev, I. V.
    Gevorgyan, A. G.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 176 - 176
  • [28] Caphosol in prevention of oral mucositis in autologous stem cell transplant recipients after high-dose melphalan (CASH)
    van Groningen, L. F. J.
    Potting, C. M. J.
    van der Velden, W. J. F. M.
    Theunissen, K.
    Maertens, J.
    Kooy, M. van Marwijk
    Schouten, H. C.
    Visser, O.
    Willems, E.
    Sonet, A.
    Blijlevens, N. M. A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S209 - S209
  • [29] Effect of probanthine on oral mucositis following high dose melphalan: A pilot study
    Ascensao, J
    Hall, S
    MacKintosh, FR
    Fonteloga, A
    Kelly, A
    Wilson, GS
    Holliday, B
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 303 - 303
  • [30] Prospective oral mucositis audit (POMA): Occurrence and consequences of severe oral mucositis in high dose melphalan and beam conditioning
    Blijlevens, N.
    McCann, S.
    Bacon, P.
    Quinn, B.
    Schwenkglcnks, M.
    Stone, R.
    Pico, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 73 - 73